JHMM 📈 John Hancock Multifactor - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US47804J2069 • Mid-Cap Blend

JHMM: Mid-cap, Stocks, US, Equities

The John Hancock Multifactor Mid Cap ETF, listed on the NYSE ARCA under the ticker JHMM, is designed to track a specific index that focuses on mid-cap companies in the U.S. market. This index is constructed to include a subset of securities from the broader U.S. Universe, specifically targeting companies with market capitalizations that fall between the 200th and 951st largest U.S. companies at the time of reconstitution. By doing so, the fund aims to provide investors with exposure to a segment of the market that may offer a balance between growth potential and stability. The fund's investment strategy involves allocating at least 80% of its net assets, plus any borrowings for investment purposes, into the securities that make up its underlying index.

As an exchange-traded fund (ETF), JHMM offers investors the benefits of diversification and flexibility, allowing them to gain exposure to a broad range of mid-cap companies through a single investment vehicle. The fund's category is classified as Mid-Cap Blend, indicating that it seeks to balance value and growth characteristics within its portfolio. With its domicile in the United States and an ISIN of US47804J2069, the John Hancock Multifactor Mid Cap ETF is designed for investors looking to tap into the U.S. mid-cap market. For more information, investors can visit the company's website at http://jhinvestments.com, which provides detailed insights into the fund's strategy, performance, and other relevant information.

By investing in the John Hancock Multifactor Mid Cap ETF, investors can potentially benefit from the fund's multifactor approach, which aims to identify and capitalize on various drivers of return across different market conditions. This approach can help in mitigating risks and enhancing returns over the long term. Furthermore, as an ETF, JHMM offers the advantage of transparency, with its holdings and performance data readily available to investors. This transparency, combined with the fund's focus on mid-cap companies, makes it an attractive option for those seeking to diversify their portfolios and tap into the growth potential of the U.S. mid-cap market.

Additional Sources for JHMM ETF

JHMM ETF Overview

Market Cap in USD 4,027m
Category Mid-Cap Blend
TER 0.42%
IPO / Inception 2015-09-28

JHMM ETF Ratings

Growth 5y 63.2%
Fundamental -
Dividend 49.0%
Rel. Strength Industry -18.6
Analysts -
Fair Price Momentum 61.33 USD
Fair Price DCF -

JHMM Dividends

Dividend Yield 12m 0.98%
Yield on Cost 5y 1.60%
Annual Growth 5y 5.26%
Payout Consistency 95.9%

JHMM Growth Ratios

Growth Correlation 3m -1.2%
Growth Correlation 12m 89%
Growth Correlation 5y 71.9%
CAGR 5y 10.34%
CAGR/Mean DD 5y 1.28
Sharpe Ratio 12m 1.13
Alpha -6.46
Beta 1.10
Volatility 16.34%
Current Volume 157k
Average Volume 20d 220.3k
What is the price of JHMM stocks?
As of January 18, 2025, the stock is trading at USD 62.16 with a total of 157,025 shares traded.
Over the past week, the price has changed by +4.58%, over one month by +0.82%, over three months by +2.05% and over the past year by +22.91%.
Is John Hancock Multifactor a good stock to buy?
Yes. Based on ValueRay Analyses, John Hancock Multifactor (NYSE ARCA:JHMM) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.24 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JHMM as of January 2025 is 61.33. This means that JHMM is currently overvalued and has a potential downside of -1.34%.
Is JHMM a buy, sell or hold?
John Hancock Multifactor has no consensus analysts rating.
What are the forecast for JHMM stock price target?
According to ValueRays Forecast Model, JHMM John Hancock Multifactor will be worth about 68.4 in January 2026. The stock is currently trading at 62.16. This means that the stock has a potential upside of +10.07%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 68.4 10.1%